-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, August 25, according to the "National Organization of Centralized Procurement of Artificial Joints" (referred to as "Documents") issued by the National Organization of High-value Medical Consumables Joint Procurement Office on the 23rd, the national centralized procurement of high-value consumables for artificial joints It will be officially launched in Tianjin on September 14
.
.
Prior to this, the collection of orthopedic joints began to warm up on April 1 this year, and the joint procurement office of high-value medical consumables organized by the state began to collect information on artificial hip joints and artificial knee joints
.
In June, the centralized procurement news was disclosed, but no details such as the proportion of the intended purchase volume, the highest effective declared price, and the time for the centralized procurement to be opened were not announced
.
.
In June, the centralized procurement news was disclosed, but no details such as the proportion of the intended purchase volume, the highest effective declared price, and the time for the centralized procurement to be opened were not announced
.
Today, orthopedic consumables stocks collectively rose in early trading.
As of now, several popular companies like iKang Medical rose 8.
93% to 9.
27 Hong Kong dollars, Chunli Medical rose 5.
75% to 21.
15 Hong Kong dollars, and MicroPort Medical rose 3.
38% to 45.
9 Hong Kong dollars
.
As of now, several popular companies like iKang Medical rose 8.
93% to 9.
27 Hong Kong dollars, Chunli Medical rose 5.
75% to 21.
15 Hong Kong dollars, and MicroPort Medical rose 3.
38% to 45.
9 Hong Kong dollars
.
The total purchase over 53 Wan Ge companies to reach 49 Jia
This time, the centralized procurement of joints is divided into four sub-categories, with a total of 537,518 intended purchases of various products
.
The intended purchase volume of each product category is based on 90% of the purchase demand of each product system reported by each medical institution (hereinafter referred to as the medical institution) participating in this centralized purchase ) Is added up
.
.
The intended purchase volume of each product category is based on 90% of the purchase demand of each product system reported by each medical institution (hereinafter referred to as the medical institution) participating in this centralized purchase ) Is added up
.
Among them, the total number of intended purchases of hip joint product systems in the first year was 305,542, including three sub-categories:
126,797 ceramic-ceramic hip joint product systems;
142,757 ceramic-polyethylene hip joint product systems;
35988 alloy-polyethylene hip joint product systems;
In addition, the total number of intended purchases of knee joint product systems in the first year was 231976
.
.
According to statistics, more than 140 products from 49 companies in this centralized procurement of artificial joints (including hip and knee joints) have obtained the procurement requirements reported by medical institutions, that is, they have obtained the qualifications to participate in centralized procurement, including domestic joints.
The top three are iKang Medical, Chunli Medical and Weigao shares
.
In addition, Dabo Medical, Shanghai MicroPort Orthopedic Medical Technology Co.
, Ltd.
and other companies are also listed
.
The top three are iKang Medical, Chunli Medical and Weigao shares
.
In addition, Dabo Medical, Shanghai MicroPort Orthopedic Medical Technology Co.
, Ltd.
and other companies are also listed
.
Price limit rules for four types of products:
Various reporting requirements
Eligibility for declaration:
Reporting companies to have achieved this focus with the amount of purchased product legally qualified medical device registrant ( proxy person), reporting companies must clearly serves regional, and promised each product system corresponds to all models for the procurement to meet the regional purchasing demand cycle
.
.
Procurement cycle: The cycle is 2 years, calculated from the actual implementation date of the selected results in each region of the alliance
.
.
Application materials, deadline for submission of materials, and disclosure of application information: all will be completed in the morning of September 14, 2021
.
.
Declared price:
It is the sum of the price of each component in the product system (including product system distribution costs, supporting tool distribution costs, and supporting tool usage costs) and accompanying service prices
.
When quoting the enterprise, it is necessary to indicate not only the declared price of the product system category, but also the unit price of each component in the product system and the price of accompanying services
.
.
When quoting the enterprise, it is necessary to indicate not only the declared price of the product system category, but also the unit price of each component in the product system and the price of accompanying services
.
The price of the same component product in different product system categories and product systems of hip or knee joints should be consistent;
The price of accompanying services of the same applying enterprise shall be consistent;
The price of acetabular screws in the same application enterprise should be consistent;
The price of patella prosthesis from the same application enterprise should be consistent;
When the declared price of the declared enterprise product system category is different from the sum of the price of each component and accompanying service price in the product system, the declared price shall prevail
.
.
Bidding unit:
Under the same product system category, according to the procurement requirements of medical institutions, enterprise supply capacity, product materials and other conditions, two groups A and B are formed, and each is a bidding unit to bid separately
.
Simultaneously satisfy the following three conditions filers into the group A, group B into the other, simply Qualification than group A to group B
.
The 3 conditions are:
.
Simultaneously satisfy the following three conditions filers into the group A, group B into the other, simply Qualification than group A to group B
.
The 3 conditions are:
1.
Take the declarer as a unit, merge all different product systems under the same product system category of the same declaring company, and sort them from most to least according to the intended purchase volume of medical institutions, and take the declaring company covered by the top 85% of the cumulative intended purchase volume;
Take the declarer as a unit, merge all different product systems under the same product system category of the same declaring company, and sort them from most to least according to the intended purchase volume of medical institutions, and take the declaring company covered by the top 85% of the cumulative intended purchase volume;
2.
The declaring enterprise promises to meet the procurement needs of all prefectures and cities in all alliance areas;
The declaring enterprise promises to meet the procurement needs of all prefectures and cities in all alliance areas;
3.
In addition to the ceramic-ceramic hip joint product system and the knee joint product system, the ceramic-polyethylene hip joint product system and the alloy-polyethylene hip joint product system declared by the enterprise have at least one product system for the acetabular lining With high cross-linked polyethylene or high cross-linked polyethylene (including antioxidant) material
.
In addition to the ceramic-ceramic hip joint product system and the knee joint product system, the ceramic-polyethylene hip joint product system and the alloy-polyethylene hip joint product system declared by the enterprise have at least one product system for the acetabular lining With high cross-linked polyethylene or high cross-linked polyethylene (including antioxidant) material
.
This means that after grouping, all hip and knee joint products are finally divided into 8 groups (8 bidding units), including ceramic-ceramic hip joint product systems (divided into two groups A and B), ceramic-polyethylene Hip joint product system (divided into two groups A and B), alloy-polyethylene hip joint product system (divided into two groups A and B), knee joint product system (divided into two groups A and B)
.
.
Proposed selection rule 1:
Within the same bidding unit, the shortlisted companies are determined according to the ranking of the companies' bid comparison prices from low to high
.
The product system bidding price of the shortlisted enterprises shall not be higher than the highest effective declared price
.
.
The product system bidding price of the shortlisted enterprises shall not be higher than the highest effective declared price
.
If the product system of the shortlisted company meets one of the following conditions, it will be eligible to be selected:
(1) The bid comparison price ≤ 1.
5 times the bid comparison price of the lowest product system of the same bidding unit;
5 times the bid comparison price of the lowest product system of the same bidding unit;
(2) Bidding comparison price> 1.
5 times the bid comparison price of the lowest product system of the same bidding unit, but the bid comparison price ≤ 50% of the highest effective declaration price of the product system category
.
5 times the bid comparison price of the lowest product system of the same bidding unit, but the bid comparison price ≤ 50% of the highest effective declaration price of the product system category
.
Proposed selection rule 2:
The declared company fails to obtain the qualification for the selection according to the proposed selection rule 1.
Within the same product system category, if the bid comparison price of group A is not higher than the bid comparison price of the highest group B, and the bid comparison price of group A is not higher than the highest price, it is valid For 50% of the declared price, the corresponding declared company whose bid price in Group A is not higher than the bid price of the highest proposed company in Group B is to be selected
.
Within the same product system category, if the bid comparison price of group A is not higher than the bid comparison price of the highest group B, and the bid comparison price of group A is not higher than the highest price, it is valid For 50% of the declared price, the corresponding declared company whose bid price in Group A is not higher than the bid price of the highest proposed company in Group B is to be selected
.
Proposed selection rule three:
The applicant enterprise fails to obtain the qualification for the proposed selection according to the proposed selection rule 1, if the ceramic-ceramic hip joint product system category enterprise bidding price is not higher than the ceramic-polyethylene hip joint product system category or alloy-polyethylene hip joint product system The ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system with the highest bid price of the highest effective bid price not higher than 50% of the highest effective declaration price
.
.
The proposed ranking is the same as the enterprise ranking rules
.
.
Principles for the allocation of procurement volume:
1.
The selected companies in the same bidding unit will allocate the agreed purchase volume in the order of the selected companies;
The selected companies in the same bidding unit will allocate the agreed purchase volume in the order of the selected companies;
2.
The remaining volume of the medical institution is composed of the intentional procurement volume of the product system that has reported the purchase demand but the unselected product, and the unallocated intentional procurement volume of the selected product.
The remaining volume of the medical institution can independently select the product with the appropriate price from the selected product system.
；
The remaining volume of the medical institution is composed of the intentional procurement volume of the product system that has reported the purchase demand but the unselected product, and the unallocated intentional procurement volume of the selected product.
The remaining volume of the medical institution can independently select the product with the appropriate price from the selected product system.
；
3.
According to the documents, the selected companies in the same bidding unit are ranked in the order of the selected ones.
The product ranked first (the lowest bid price) can get 100% of the intended purchase volume, and the second and third products will get 90% and 85% respectively.
The amount of intended purchases, and so on
.
According to the documents, the selected companies in the same bidding unit are ranked in the order of the selected ones.
The product ranked first (the lowest bid price) can get 100% of the intended purchase volume, and the second and third products will get 90% and 85% respectively.
The amount of intended purchases, and so on
.
The demand for joint consumables is large, so centralized procurement is imperative
At present, the level of localization in the joint field is low.
Foreign-funded companies like Zimmer, Stryker, Johnson & Johnson, and Xerox Hui account for 74%.
The domestic companies with the largest sales of artificial joints are Weigao Orthopedics, Akcome Medical, and Chunli Medical Three listed companies
.
Among them, Weigao Orthopedics achieved revenue of 1.
824 billion yuan in 2020, and it is the leading domestic enterprise
.
However, domestic production is obviously at a disadvantage, and centralized procurement will help the leading enterprises in the joint field quickly occupy the domestic market share
.
Foreign-funded companies like Zimmer, Stryker, Johnson & Johnson, and Xerox Hui account for 74%.
The domestic companies with the largest sales of artificial joints are Weigao Orthopedics, Akcome Medical, and Chunli Medical Three listed companies
.
Among them, Weigao Orthopedics achieved revenue of 1.
824 billion yuan in 2020, and it is the leading domestic enterprise
.
However, domestic production is obviously at a disadvantage, and centralized procurement will help the leading enterprises in the joint field quickly occupy the domestic market share
.
Regarding the impact of the centralized procurement of artificial joints, the relevant person stated that artificial joints are the first product category to carry out centralized procurement in the entire orthopedics industry.
The centralized procurement of joints has fully considered the clinical needs, classified companies and materials, and avoided maliciousness as much as possible.
With the risk of low-price competition, domestic head companies in orthopedic joints are expected to further expand their market share in centralized procurement, and the substitution of domestic imports will accelerate
.
Centralized procurement will have a profound impact on the orthopedics industry.
In the future, the market concentration of the orthopedics industry will further increase under the influence of the national centralized procurement policy
.
In the long run, centralized procurement will have a positive impact on leading companies with original R&D and innovation capabilities and a leading scale
.
The centralized procurement of joints has fully considered the clinical needs, classified companies and materials, and avoided maliciousness as much as possible.
With the risk of low-price competition, domestic head companies in orthopedic joints are expected to further expand their market share in centralized procurement, and the substitution of domestic imports will accelerate
.
Centralized procurement will have a profound impact on the orthopedics industry.
In the future, the market concentration of the orthopedics industry will further increase under the influence of the national centralized procurement policy
.
In the long run, centralized procurement will have a positive impact on leading companies with original R&D and innovation capabilities and a leading scale
.
Medical Network, August 25, according to the "National Organization of Centralized Procurement of Artificial Joints" (referred to as "Documents") issued by the National Organization of High-value Medical Consumables Joint Procurement Office on the 23rd, the national centralized procurement of high-value consumables for artificial joints It will be officially launched in Tianjin on September 14
.
.
Prior to this, the collection of orthopedic joints began to warm up on April 1 this year, and the joint procurement office of high-value medical consumables organized by the state began to collect information on artificial hip joints and artificial knee joints
.
In June, the centralized procurement news was disclosed, but no details such as the proportion of the intended purchase volume, the highest effective declared price, and the time for the centralized procurement to be opened were not announced
.
.
In June, the centralized procurement news was disclosed, but no details such as the proportion of the intended purchase volume, the highest effective declared price, and the time for the centralized procurement to be opened were not announced
.
Today, orthopedic consumables stocks collectively rose in early trading.
As of now, several popular companies like iKang Medical rose 8.
93% to 9.
27 Hong Kong dollars, Chunli Medical rose 5.
75% to 21.
15 Hong Kong dollars, and MicroPort Medical rose 3.
38% to 45.
9 Hong Kong dollars
.
As of now, several popular companies like iKang Medical rose 8.
93% to 9.
27 Hong Kong dollars, Chunli Medical rose 5.
75% to 21.
15 Hong Kong dollars, and MicroPort Medical rose 3.
38% to 45.
9 Hong Kong dollars
.
The total purchase over 53 Wan Ge companies to reach 49 Jia
This time, the centralized procurement of joints is divided into four sub-categories, with a total of 537,518 intended purchases of various products
.
The intended purchase volume of each product category is based on 90% of the purchase demand of each product system reported by each medical institution (hereinafter referred to as the medical institution) participating in this centralized purchase ) Is added up
.
.
The intended purchase volume of each product category is based on 90% of the purchase demand of each product system reported by each medical institution (hereinafter referred to as the medical institution) participating in this centralized purchase ) Is added up
.
Among them, the total number of intended purchases of hip joint product systems in the first year was 305,542, including three sub-categories:
126,797 ceramic-ceramic hip joint product systems;
142,757 ceramic-polyethylene hip joint product systems;
35988 alloy-polyethylene hip joint product systems;
In addition, the total number of intended purchases of knee joint product systems in the first year was 231976
.
.
According to statistics, more than 140 products from 49 companies in this centralized procurement of artificial joints (including hip and knee joints) have obtained the procurement requirements reported by medical institutions, that is, they have obtained the qualifications to participate in centralized procurement, including domestic joints.
The top three are iKang Medical, Chunli Medical and Weigao shares
.
In addition, Dabo Medical, Shanghai MicroPort Orthopedic Medical Technology Co.
, Ltd.
and other companies are also listed
.
The top three are iKang Medical, Chunli Medical and Weigao shares
.
In addition, Dabo Medical, Shanghai MicroPort Orthopedic Medical Technology Co.
, Ltd.
and other companies are also listed
.
Price limit rules for four types of products:
Various reporting requirements
Eligibility for declaration:
Reporting companies to have achieved this focus with the amount of purchased product legally qualified medical device registrant ( proxy person), reporting companies must clearly serves regional, and promised each product system corresponds to all models for the procurement to meet the regional purchasing demand cycle
.
.
Procurement cycle: The cycle is 2 years, calculated from the actual implementation date of the selected results in each region of the alliance
.
.
Application materials, deadline for submission of materials, and disclosure of application information: all will be completed in the morning of September 14, 2021
.
.
Declared price:
It is the sum of the price of each component in the product system (including product system distribution costs, supporting tool distribution costs, and supporting tool usage costs) and accompanying service prices
.
When quoting the enterprise, it is necessary to indicate not only the declared price of the product system category, but also the unit price of each component in the product system and the price of accompanying services
.
.
When quoting the enterprise, it is necessary to indicate not only the declared price of the product system category, but also the unit price of each component in the product system and the price of accompanying services
.
The price of the same component product in different product system categories and product systems of hip or knee joints should be consistent;
The price of accompanying services of the same applying enterprise shall be consistent;
The price of acetabular screws in the same application enterprise should be consistent;
The price of patella prosthesis from the same application enterprise should be consistent;
When the declared price of the declared enterprise product system category is different from the sum of the price of each component and accompanying service price in the product system, the declared price shall prevail
.
.
Bidding unit:
Under the same product system category, according to the procurement requirements of medical institutions, enterprise supply capacity, product materials and other conditions, two groups A and B are formed, and each is a bidding unit to bid separately
.
Simultaneously satisfy the following three conditions filers into the group A, group B into the other, simply Qualification than group A to group B
.
The 3 conditions are:
.
Simultaneously satisfy the following three conditions filers into the group A, group B into the other, simply Qualification than group A to group B
.
The 3 conditions are:
1.
Take the declarer as a unit, merge all different product systems under the same product system category of the same declaring company, and sort them from most to least according to the intended purchase volume of medical institutions, and take the declaring company covered by the top 85% of the cumulative intended purchase volume;
Take the declarer as a unit, merge all different product systems under the same product system category of the same declaring company, and sort them from most to least according to the intended purchase volume of medical institutions, and take the declaring company covered by the top 85% of the cumulative intended purchase volume;
2.
The declaring enterprise promises to meet the procurement needs of all prefectures and cities in all alliance areas;
The declaring enterprise promises to meet the procurement needs of all prefectures and cities in all alliance areas;
3.
In addition to the ceramic-ceramic hip joint product system and the knee joint product system, the ceramic-polyethylene hip joint product system and the alloy-polyethylene hip joint product system declared by the enterprise have at least one product system for the acetabular lining With high cross-linked polyethylene or high cross-linked polyethylene (including antioxidant) material
.
In addition to the ceramic-ceramic hip joint product system and the knee joint product system, the ceramic-polyethylene hip joint product system and the alloy-polyethylene hip joint product system declared by the enterprise have at least one product system for the acetabular lining With high cross-linked polyethylene or high cross-linked polyethylene (including antioxidant) material
.
This means that after grouping, all hip and knee joint products are finally divided into 8 groups (8 bidding units), including ceramic-ceramic hip joint product systems (divided into two groups A and B), ceramic-polyethylene Hip joint product system (divided into two groups A and B), alloy-polyethylene hip joint product system (divided into two groups A and B), knee joint product system (divided into two groups A and B)
.
.
Proposed selection rule 1:
Within the same bidding unit, the shortlisted companies are determined according to the ranking of the companies' bid comparison prices from low to high
.
The product system bidding price of the shortlisted enterprises shall not be higher than the highest effective declared price
.
.
The product system bidding price of the shortlisted enterprises shall not be higher than the highest effective declared price
.
If the product system of the shortlisted company meets one of the following conditions, it will be eligible to be selected:
(1) The bid comparison price ≤ 1.
5 times the bid comparison price of the lowest product system of the same bidding unit;
5 times the bid comparison price of the lowest product system of the same bidding unit;
(2) Bidding comparison price> 1.
5 times the bid comparison price of the lowest product system of the same bidding unit, but the bid comparison price ≤ 50% of the highest effective declaration price of the product system category
.
5 times the bid comparison price of the lowest product system of the same bidding unit, but the bid comparison price ≤ 50% of the highest effective declaration price of the product system category
.
Proposed selection rule 2:
The declared company fails to obtain the qualification for the selection according to the proposed selection rule 1.
Within the same product system category, if the bid comparison price of group A is not higher than the bid comparison price of the highest group B, and the bid comparison price of group A is not higher than the highest price, it is valid For 50% of the declared price, the corresponding declared company whose bid price in Group A is not higher than the bid price of the highest proposed company in Group B is to be selected
.
Within the same product system category, if the bid comparison price of group A is not higher than the bid comparison price of the highest group B, and the bid comparison price of group A is not higher than the highest price, it is valid For 50% of the declared price, the corresponding declared company whose bid price in Group A is not higher than the bid price of the highest proposed company in Group B is to be selected
.
Proposed selection rule three:
The applicant enterprise fails to obtain the qualification for the proposed selection according to the proposed selection rule 1, if the ceramic-ceramic hip joint product system category enterprise bidding price is not higher than the ceramic-polyethylene hip joint product system category or alloy-polyethylene hip joint product system The ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system with the highest bid price of the highest effective bid price not higher than 50% of the highest effective declaration price
.
.
The proposed ranking is the same as the enterprise ranking rules
.
.
Principles for the allocation of procurement volume:
1.
The selected companies in the same bidding unit will allocate the agreed purchase volume in the order of the selected companies;
The selected companies in the same bidding unit will allocate the agreed purchase volume in the order of the selected companies;
2.
The remaining volume of the medical institution is composed of the intentional procurement volume of the product system that has reported the purchase demand but the unselected product, and the unallocated intentional procurement volume of the selected product.
The remaining volume of the medical institution can independently select the product with the appropriate price from the selected product system.
；
The remaining volume of the medical institution is composed of the intentional procurement volume of the product system that has reported the purchase demand but the unselected product, and the unallocated intentional procurement volume of the selected product.
The remaining volume of the medical institution can independently select the product with the appropriate price from the selected product system.
；
3.
According to the documents, the selected companies in the same bidding unit are ranked in the order of the selected ones.
The product ranked first (the lowest bid price) can get 100% of the intended purchase volume, and the second and third products will get 90% and 85% respectively.
The amount of intended purchases, and so on
.
According to the documents, the selected companies in the same bidding unit are ranked in the order of the selected ones.
The product ranked first (the lowest bid price) can get 100% of the intended purchase volume, and the second and third products will get 90% and 85% respectively.
The amount of intended purchases, and so on
.
The demand for joint consumables is large, so centralized procurement is imperative
At present, the level of localization in the joint field is low.
Foreign-funded companies like Zimmer, Stryker, Johnson & Johnson, and Xerox Hui account for 74%.
The domestic companies with the largest sales of artificial joints are Weigao Orthopedics, Akcome Medical, and Chunli Medical Three listed companies
.
Among them, Weigao Orthopedics achieved revenue of 1.
824 billion yuan in 2020, and it is the leading domestic enterprise
.
However, domestic production is obviously at a disadvantage, and centralized procurement will help the leading enterprises in the joint field quickly occupy the domestic market share
.
Foreign-funded companies like Zimmer, Stryker, Johnson & Johnson, and Xerox Hui account for 74%.
The domestic companies with the largest sales of artificial joints are Weigao Orthopedics, Akcome Medical, and Chunli Medical Three listed companies
.
Among them, Weigao Orthopedics achieved revenue of 1.
824 billion yuan in 2020, and it is the leading domestic enterprise
.
However, domestic production is obviously at a disadvantage, and centralized procurement will help the leading enterprises in the joint field quickly occupy the domestic market share
.
Regarding the impact of the centralized procurement of artificial joints, the relevant person stated that artificial joints are the first product category to carry out centralized procurement in the entire orthopedics industry.
The centralized procurement of joints has fully considered the clinical needs, classified companies and materials, and avoided maliciousness as much as possible.
With the risk of low-price competition, domestic head companies in orthopedic joints are expected to further expand their market share in centralized procurement, and the substitution of domestic imports will accelerate
.
Centralized procurement will have a profound impact on the orthopedics industry.
In the future, the market concentration of the orthopedics industry will further increase under the influence of the national centralized procurement policy
.
In the long run, centralized procurement will have a positive impact on leading companies with original R&D and innovation capabilities and a leading scale
.
The centralized procurement of joints has fully considered the clinical needs, classified companies and materials, and avoided maliciousness as much as possible.
With the risk of low-price competition, domestic head companies in orthopedic joints are expected to further expand their market share in centralized procurement, and the substitution of domestic imports will accelerate
.
Centralized procurement will have a profound impact on the orthopedics industry.
In the future, the market concentration of the orthopedics industry will further increase under the influence of the national centralized procurement policy
.
In the long run, centralized procurement will have a positive impact on leading companies with original R&D and innovation capabilities and a leading scale
.
Medical Network, August 25, according to the "National Organization of Centralized Procurement of Artificial Joints" (referred to as "Documents") issued by the National Organization of High-value Medical Consumables Joint Procurement Office on the 23rd, the national centralized procurement of high-value consumables for artificial joints It will be officially launched in Tianjin on September 14
.
.
Prior to this, the collection of orthopedic joints began to warm up on April 1 this year, and the joint procurement office of high-value medical consumables organized by the state began to collect information on artificial hip joints and artificial knee joints
.
In June, the centralized procurement news was disclosed, but no details such as the proportion of the intended purchase volume, the highest effective declared price, and the time for the centralized procurement to be opened were not announced
.
.
In June, the centralized procurement news was disclosed, but no details such as the proportion of the intended purchase volume, the highest effective declared price, and the time for the centralized procurement to be opened were not announced
.
Today, orthopedic consumables stocks collectively rose in early trading.
As of now, several popular companies like iKang Medical rose 8.
93% to 9.
27 Hong Kong dollars, Chunli Medical rose 5.
75% to 21.
15 Hong Kong dollars, and MicroPort Medical rose 3.
38% to 45.
9 Hong Kong dollars
.
As of now, several popular companies like iKang Medical rose 8.
93% to 9.
27 Hong Kong dollars, Chunli Medical rose 5.
75% to 21.
15 Hong Kong dollars, and MicroPort Medical rose 3.
38% to 45.
9 Hong Kong dollars
.
The total purchase over 53 Wan Ge companies to reach 49 Jia
The total purchase over 53 Wan Ge companies to reach 49 Jia This time, the centralized procurement of joints is divided into four sub-categories, with a total of 537,518 intended purchases of various products
.
The intended purchase volume of each product category is based on 90% of the purchase demand of each product system reported by each medical institution (hereinafter referred to as the medical institution) participating in this centralized purchase ) Is added up
.
.
The intended purchase volume of each product category is based on 90% of the purchase demand of each product system reported by each medical institution (hereinafter referred to as the medical institution) participating in this centralized purchase ) Is added up
.
Among them, the total number of intended purchases of hip joint product systems in the first year was 305,542, including three sub-categories:
126,797 ceramic-ceramic hip joint product systems;
142,757 ceramic-polyethylene hip joint product systems;
35988 alloy-polyethylene hip joint product systems;
In addition, the total number of intended purchases of knee joint product systems in the first year was 231976
.
.
According to statistics, more than 140 products from 49 companies in this centralized procurement of artificial joints (including hip and knee joints) have obtained the procurement requirements reported by medical institutions, that is, they have obtained the qualifications to participate in centralized procurement, including domestic joints.
The top three are iKang Medical, Chunli Medical and Weigao shares
.
In addition, Dabo Medical, Shanghai MicroPort Orthopedic Medical Technology Co.
, Ltd.
and other companies are also listed
.
The top three are iKang Medical, Chunli Medical and Weigao shares
.
In addition, Dabo Medical, Shanghai MicroPort Orthopedic Medical Technology Co.
, Ltd.
and other companies are also listed
.
Price limit rules for four types of products:
Various reporting requirements
Various reporting requirements Eligibility for declaration:
Eligibility for declaration: Reporting companies to have achieved this focus with the amount of purchased product legally qualified medical device registrant ( proxy person), reporting companies must clearly serves regional, and promised each product system corresponds to all models for the procurement to meet the regional purchasing demand cycle
.
Medical equipment medical equipment medical equipment agent agent agent enterprise enterprise corporate procurement procurement procurement.
Procurement cycle: The cycle is 2 years, calculated from the actual implementation date of the selected results in each region of the alliance
.
.
Application materials, deadline for submission of materials, and disclosure of application information: all will be completed in the morning of September 14, 2021
.
.
Declared price:
Declared price: It is the sum of the price of each component in the product system (including product system distribution costs, supporting tool distribution costs, and supporting tool usage costs) and accompanying service prices
.
When quoting the enterprise, it is necessary to indicate not only the declared price of the product system category, but also the unit price of each component in the product system and the price of accompanying services
.
.
When quoting the enterprise, it is necessary to indicate not only the declared price of the product system category, but also the unit price of each component in the product system and the price of accompanying services
.
The price of the same component product in different product system categories and product systems of hip or knee joints should be consistent;
The price of accompanying services of the same applying enterprise shall be consistent;
The price of acetabular screws in the same application enterprise should be consistent;
The price of patella prosthesis from the same application enterprise should be consistent;
When the declared price of the declared enterprise product system category is different from the sum of the price of each component and accompanying service price in the product system, the declared price shall prevail
.
.
Bidding unit:
Bidding unit: Under the same product system category, according to the procurement requirements of medical institutions, enterprise supply capacity, product materials and other conditions, two groups A and B are formed, and each is a bidding unit to bid separately
.
Simultaneously satisfy the following three conditions filers into the group A, group B into the other, simply Qualification than group A to group B
.
The 3 conditions are:
.
Simultaneously satisfy the following three conditions filers into the group A, group B into the other, simply Qualification than group A to group B
.
The 3 conditions are:
1.
Take the declarer as a unit, merge all different product systems under the same product system category of the same declaring company, and sort them from most to least according to the intended purchase volume of medical institutions, and take the declaring company covered by the top 85% of the cumulative intended purchase volume;
Take the declarer as a unit, merge all different product systems under the same product system category of the same declaring company, and sort them from most to least according to the intended purchase volume of medical institutions, and take the declaring company covered by the top 85% of the cumulative intended purchase volume;
2.
The declaring enterprise promises to meet the procurement needs of all prefectures and cities in all alliance areas;
The declaring enterprise promises to meet the procurement needs of all prefectures and cities in all alliance areas;
3.
In addition to the ceramic-ceramic hip joint product system and the knee joint product system, the ceramic-polyethylene hip joint product system and the alloy-polyethylene hip joint product system declared by the enterprise have at least one product system for the acetabular lining With high cross-linked polyethylene or high cross-linked polyethylene (including antioxidant) material
.
In addition to the ceramic-ceramic hip joint product system and the knee joint product system, the ceramic-polyethylene hip joint product system and the alloy-polyethylene hip joint product system declared by the enterprise have at least one product system for the acetabular lining With high cross-linked polyethylene or high cross-linked polyethylene (including antioxidant) material
.
This means that after grouping, all hip and knee joint products are finally divided into 8 groups (8 bidding units), including ceramic-ceramic hip joint product systems (divided into two groups A and B), ceramic-polyethylene Hip joint product system (divided into two groups A and B), alloy-polyethylene hip joint product system (divided into two groups A and B), knee joint product system (divided into two groups A and B)
.
.
Proposed selection rule 1:
Proposed selection rule 1: Within the same bidding unit, the shortlisted companies are determined according to the ranking of the companies' bid comparison prices from low to high
.
The product system bidding price of the shortlisted enterprises shall not be higher than the highest effective declared price
.
.
The product system bidding price of the shortlisted enterprises shall not be higher than the highest effective declared price
.
If the product system of the shortlisted company meets one of the following conditions, it will be eligible to be selected:
(1) The bid comparison price ≤ 1.
5 times the bid comparison price of the lowest product system of the same bidding unit;
5 times the bid comparison price of the lowest product system of the same bidding unit;
(2) Bidding comparison price> 1.
5 times the bid comparison price of the lowest product system of the same bidding unit, but the bid comparison price ≤ 50% of the highest effective declaration price of the product system category
.
5 times the bid comparison price of the lowest product system of the same bidding unit, but the bid comparison price ≤ 50% of the highest effective declaration price of the product system category
.
Proposed selection rule 2:
Proposed selection rule 2: The declared company fails to obtain the qualification for the selection according to the proposed selection rule 1.
Within the same product system category, if the bid comparison price of group A is not higher than the bid comparison price of the highest group B, and the bid comparison price of group A is not higher than the highest price, it is valid For 50% of the declared price, the corresponding declared company whose bid price in Group A is not higher than the bid price of the highest proposed company in Group B is to be selected
.
Within the same product system category, if the bid comparison price of group A is not higher than the bid comparison price of the highest group B, and the bid comparison price of group A is not higher than the highest price, it is valid For 50% of the declared price, the corresponding declared company whose bid price in Group A is not higher than the bid price of the highest proposed company in Group B is to be selected
.
Proposed selection rule three:
Proposed selection rule three: The applicant enterprise fails to obtain the qualification for the proposed selection according to the proposed selection rule 1, if the ceramic-ceramic hip joint product system category enterprise bidding price is not higher than the ceramic-polyethylene hip joint product system category or alloy-polyethylene hip joint product system The ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system corresponding to the ceramic-ceramic hip joint product system with the highest bid price of the highest effective bid price not higher than 50% of the highest effective declaration price
.
.
The proposed ranking is the same as the enterprise ranking rules
.
.
Principles for the allocation of procurement volume:
Principles for the allocation of procurement volume: 1.
The selected companies in the same bidding unit will allocate the agreed purchase volume in the order of the selected companies;
The selected companies in the same bidding unit will allocate the agreed purchase volume in the order of the selected companies;
2.
The remaining volume of the medical institution is composed of the intentional procurement volume of the product system that has reported the purchase demand but the unselected product, and the unallocated intentional procurement volume of the selected product.
The remaining volume of the medical institution can independently select the product with the appropriate price from the selected product system.
；
The remaining volume of the medical institution is composed of the intentional procurement volume of the product system that has reported the purchase demand but the unselected product, and the unallocated intentional procurement volume of the selected product.
The remaining volume of the medical institution can independently select the product with the appropriate price from the selected product system.
；
3.
According to the documents, the selected companies in the same bidding unit are ranked in the order of the selected ones.
The product ranked first (the lowest bid price) can get 100% of the intended purchase volume, and the second and third products will get 90% and 85% respectively.
The amount of intended purchases, and so on
.
According to the documents, the selected companies in the same bidding unit are ranked in the order of the selected ones.
The product ranked first (the lowest bid price) can get 100% of the intended purchase volume, and the second and third products will get 90% and 85% respectively.
The amount of intended purchases, and so on
.
The demand for joint consumables is large, so centralized procurement is imperative
The demand for joint consumables is large, so centralized procurement is imperative At present, the level of localization in the joint field is low.
Foreign-funded companies like Zimmer, Stryker, Johnson & Johnson, and Xerox Hui account for 74%.
The domestic companies with the largest sales of artificial joints are Weigao Orthopedics, Akcome Medical, and Chunli Medical Three listed companies
.
Among them, Weigao Orthopedics achieved revenue of 1.
824 billion yuan in 2020, and it is the leading domestic enterprise
.
However, domestic production is obviously at a disadvantage, and centralized procurement will help the leading enterprises in the joint field quickly occupy the domestic market share
.
Foreign-funded companies like Zimmer, Stryker, Johnson & Johnson, and Xerox Hui account for 74%.
The domestic companies with the largest sales of artificial joints are Weigao Orthopedics, Akcome Medical, and Chunli Medical Three listed companies
.
Among them, Weigao Orthopedics achieved revenue of 1.
824 billion yuan in 2020, and it is the leading domestic enterprise
.
However, domestic production is obviously at a disadvantage, and centralized procurement will help the leading enterprises in the joint field quickly occupy the domestic market share
.
Regarding the impact of the centralized procurement of artificial joints, the relevant person stated that artificial joints are the first product category to carry out centralized procurement in the entire orthopedics industry.
The centralized procurement of joints has fully considered the clinical needs, classified companies and materials, and avoided maliciousness as much as possible.
With the risk of low-price competition, domestic head companies in orthopedic joints are expected to further expand their market share in centralized procurement, and the substitution of domestic imports will accelerate
.
Centralized procurement will have a profound impact on the orthopedics industry.
In the future, the market concentration of the orthopedics industry will further increase under the influence of the national centralized procurement policy
.
In the long run, centralized procurement will have a positive impact on leading companies with original R&D and innovation capabilities and a leading scale
.
The centralized procurement of joints has fully considered the clinical needs, classified companies and materials, and avoided maliciousness as much as possible.
With the risk of low-price competition, domestic head companies in orthopedic joints are expected to further expand their market share in centralized procurement, and the substitution of domestic imports will accelerate
.
Centralized procurement will have a profound impact on the orthopedics industry.
In the future, the market concentration of the orthopedics industry will further increase under the influence of the national centralized procurement policy
.
In the long run, centralized procurement will have a positive impact on leading companies with original R&D and innovation capabilities and a leading scale
.
